On Friday, BioNano Genomics Inc (BNGO) stock saw a decline, ending the day at $0.25 which represents a decrease of $-0.01 or -3.85% from the prior close of $0.26. The stock opened at $0.25 and touched ...

Fintel reports that on November 15, 2024, Ladenburg Thalmann downgraded their outlook for Bionano Genomics (NasdaqCM:BNGO) ...

Genomics Australia will prioritise improving access to personalised cancer care. The government is establishing Genomics ...

Ladenburg downgraded Bionano Genomics (BNGO) to Neutral from Buy without a price target The company reported Q3 revenue down 35% ...

The updated Dante Labs Whole Genome platform with Generative AI features will be available globally starting Q1 2025, with ...

The molecular sensing technology can quickly analyze genes and pathogens, cutting diagnosis times to a matter of hours.

According to Research by , Rising Demand for Personalized Health Solutions and Proactive Health Management Drives Robust Growth in Predictive Genetic Testing MarketAustin, Nov. 14, 2024 (GLOBE ...

Bionano Genomics ( (BNGO) ) has released its Q3 earnings. Here is a breakdown of the information Bionano Genomics presented to its investors.

The Albanese Government is establishing a new national body to provide leadership, coordination and expertise so all ...

Based on offerings, the genomics market is divided into product and service segments. The product segment accounted for the ...

Thank you, operator, and good afternoon, everyone. Welcome to the Bionano third quarter 2024 financial results conference ...

Bionano Genomics BNGO will release its quarterly earnings report on Wednesday, 2024-11-13. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Bionano Genomics to ...